PBK and central nervous system cancer: Using the analysis of variance (ANOVA) and the p-value < 0.05, we validated that CDK1, PBK, and CHEK1 are all overexpressed in WHO glioma grades II-IV as illustrated in Figure 4D–F below, obtained from the analysis of the genes on the CGGA.